NCT03673085View on ClinicalTrials.gov

Clinical Study of CN128 in Thalassemia Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 5, 2018

Primary Completion Date

October 16, 2018

Study Completion Date

December 17, 2019

Conditions
Thalassemia
Interventions
DRUG

CN128

CN128

OTHER

placebo

The tablets without CN128

Trial Locations (1)

310003

The first affiliated hospital, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Hangzhou Zede Pharma-Tech Co., Ltd.

OTHER

NCT03673085 - Clinical Study of CN128 in Thalassemia Patients | Biotech Hunter | Biotech Hunter